Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 2, 2009, Pages 320-333

  Aliev, Gjumrakch ^a   Liu, Jiankang ^b,c   Shenk, Justin C ^a   Fischbach, Kathryn ^a   Pacheco, Gerardo J ^a   Chen, Shu G ^d   Obrenovich, Mark E ^d   Ward, Walter F ^e   Richardson, Arlan G ^e   Smith, Mark A ^d   Gasimov, Eldar ^f   Perry, George ^a,d   Ames, Bruce N ^b,c  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f AZERBAIJAN MEDICAL UNIVERSITY   (Azerbaijan)

Author keywords

Acetyl L carnitine (ALCAR); Electron microscopy; Mitochondrial oxidation; Morphometry; Neuronal mitochondria; R alpha lipoic acid (LA)

Indexed keywords

ACETYLCARNITINE; THIOCTIC ACID;

AGING; ANIMAL; ARTICLE; CYTOLOGY; DIET SUPPLEMENTATION; DRUG EFFECT; FISCHER 344 RAT; HIPPOCAMPUS; MALE; MITOCHONDRION; NERVE CELL; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; RAT; ULTRASTRUCTURE;

ACETYLCARNITINE; AGING; ANIMALS; DIETARY SUPPLEMENTS; HIPPOCAMPUS; MALE; MITOCHONDRIA; NEURONS; RANDOM ALLOCATION; RATS; RATS, INBRED F344; THIOCTIC ACID;

ANIMALIA; RATTUS;

EID: 61349084847     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00324.x     Document Type: Article

References (58)

1. de Grey ADJ. The mitochondrial free radical theory of aging. Georgetown, TX : R.G. Landers Company 1999.
2. Hagen TM, Yowe DL, Bartholomew JC, Wehr CM, Do KL, Park JY, Ames BN. Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. Proc NatlAcad Sci USA. 1997 94 : 3064 9.
3. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA. 1994 91 : 10771 8.
4. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005 39 : 359 407.
5. Sohal RS, Mockett RJ, Orr WC. Mechanisms of aging: an appraisal of the oxidative stress hypothesis. Free Radic BiolMed. 2002 33 : 575 86.
6. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science. 1996 273 : 59 63.
7. Stadtman ER. Protein oxidation and aging. Science. 1992 257 : 1220 4.
8. Stadtman ER, Levine RL. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids. 2003 25 : 207 18.
9. Feuers RJ. The effects of dietary restriction on mitochondrial dysfunction in aging. Ann N Y Acad Sci. 1998 854 : 192 201.
10. Paradies G, Ruggiero FM, Petrosillo G, Gadaleta MN, Quagliariello E. Effect of aging and acetyl-L-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria. FEBS Lett. 1994 350 : 213 5.
11. Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA. Role of mitochondrial dysfunction in Alzheimer's disease. JNeurosci Res. 2002 70 : 357 60.
12. Gibson GE, Sheu KF, Blass JP. Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm. 1998 105 : 855 70.
13. Obrenovich ME, Smith MA, Siedlak SL, Chen SG, de la Torre JC, Perry G, Aliev G. Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotox Res. 2006 10 : 43 56.
14. Zhu X, Smith MA, Perry G, Aliev G. Mitochondrial failures in Alzheimer's disease. Am J Alzheimer's Dis Other Demen. 2004 19 : 345 52.
15. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci. 2001 21 : 3017 23.
16. Aliev G, Smith MA, de la Torre JC, Perry G. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion. 2004 4 : 649 63.
17. Aliyev A, Chen SG, Seyidova D, Smith MA, Perry G, de la Torre J, Aliev G. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. J Neurol Sci. 2005 229-230 : 285 92.
18. Hagen TM, Ingersoll RT, Lykkesfeldt J, Liu J, Wehr CM, Vinarsky V, Bartholomew JC, Ames AB. (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J. 1999 13 : 411 8.
19. Hagen TM, Ingersoll RT, Wehr CM, Lykkesfeldt J, Vinarsky V, Bartholomew JC, Song MH, Ames BN. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc Natl Acad Sci USA. 1998 95 : 9562 6.
20. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V, Bartholomew JC, Ames BN. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci USA. 2002 99 : 1870 5.
21. Hagen TM, Vinarsky V, Wehr CM, Ames BN. (R)-alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo. Antioxid Redox Signal. 2000 2 : 473 83.
22. Liu J, Atamna H, Kuratsune H, Ames BN. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann N Y Acad Sci. 2002 959 : 133 66.
23. Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman CW, Ames BN. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc NatlAcad Sci USA. 2002 99 : 2356 61.
24. Liu J, Killilea DW, Ames BN. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc Natl Acad Sci USA. 2002 99 : 1876 81.
25. Aliev G, Smith MA, Seyidova D, Neal ML, Lamb BT, Nunomura A, Gasimov EK, Vinters HV, Perry G, LaManna JC, Friedland RP. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol. 2002 12 : 21 35.
26. Aliev G, Seyidova D, Lamb BT, Obrenovich ME, Siedlak SL, Vinters HV, Friedland RP, LaManna JC, Smith MA, Perry G. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurol Res. 2003 25 : 665 74.
27. Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, Vinters HV, Head E, Perry G, LaManna JC, Friedland RP, Cotman CW. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann N Y Acad Sci. 2002 977 : 45 64.
28. Aliyev A, Seyidova D, Rzayev N, Obrenovich ME, Lamb BT, Chen SG, Smith MA, Perry G, de la Torre JC, Aliev G. Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease Neurol Res. 2004 26 : 547 53.
29. Aliev G, Cirillo R, Salvatico E, Paro M, Prosdocimi M. Changes in vessel ultra-structure during ischemia and reperfusion of rabbit hindlimb: implications for therapeutic intervention. Microvasc Res. 1993 46 : 65 76.
30. Aliev G, Smith MA, Obrenovich ME, Perry G. Role of vascular hypoperfusion-induced oxidative stress and mitochondrial failure in the pathogenesis of Alzheimer disease. Neurotox Res. 2003 5 : 385 90.
31. Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, Hirai K, Smith VA. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J Alzheimer's Dis. 2006 9 : 147 53.
32. Roubertoux PL, Sluyter F, Carlier M, Marcet B, Maarouf-Veray F, Cherif C, Marican C, Arrechi P, Godin F, Jamon M, Verrier B, Cohen-Salmon C. Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice. Nat Genet. 2003 35 : 65 9.
33. Coskun PE, Beal MF, Wallace DC. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA. 2004 101 : 10726 31.
34. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science. 2004 304 : 448 52.
35. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, Wallace DC, Rabinovitch PS. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science. 2005 308 : 1909 11.
36. Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula-Barbosa M, Avila J, Jones PK, Castellani RJ, Smith MA, Perry G. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. AmJPathol. 2003 162 : 1623 7.
37. Montgomery SA, Thai LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carni-tine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol. 2003 18 : 61 71.
38. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004 5 : 133 9.
39. Murasko DM, Goonewardene IM. T-cell function in aging: mechanisms of decline. Annu Rev Gerontol Geriatr. 1990 10 : 71 96.
40. Pahlavani MA, Harris MD. Effect of dehydroepiandrosterone on mitogen-induced lymphocyte proliferation and cytokine production in young and old F344 rats. Immunol Lett. 1995 47 : 9 14.
41. Pahlavani MA, Vargas DM, Guo Z, Richardson A. Normal immune function in young and old DNA polymerase-beta deficient mice. Immunol Lett. 2000 72 : 17 21.
42. Pahlavani MA, Harris MD. Effect of in vitro generation of oxygen free radicals on T cell function in young and old rats. Free Radic BiolMed. 1998 25 : 903 13.
43. Angelucci L, Ramacci MT. Hypothalamo-pituitaryadrenocortical function in aging: effects of acetyl-L-carnitine. In : De Simone C, Arrigoni-Martelli E, editors. Stress, immunity and ageing: a role for acetyl-L-carnitine. Amsterdam : Elsevier 1989. pp. 109 18.
44. Franceschi C, Cossarizza A, Troiano L, Salati R, Monti D. Immunological parameters in aging: studies on natural immunomodulatory and immunoprotective substances. Int J Clin Pharmacol Res. 1990 10 : 53 7.
45. McMackin CJ, Widlansky ME, Hamburg NM, Huang AL, Weller S, Holbrook M, Gokce N, Hagen TM, Keaney JF Jr., Vita JA. Effect of combined treatment with alpha-Lipoic acid and acetyl-L-carnitine on vascular function and blood pressure in patients with coronary artery disease. J Clin Hypertens (Greenwich). 2007 9 : 249 55.
46. Sola S, Mir MQ, Cheema FA, Khan-Merchant N, Menon RG, Parthasarathy S, Khan BV. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation. 2005 111 : 343 8.
47. Morcos M, Borcea V, Isermann B, Gehrke S, Ehret T, Henkels M, Schiekofer S, Hofmann M, Amiral J, Tritschler H, Ziegler R, Wahl P, Nawroth PP. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract 2001 52 : 175 83.
48. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K, Kerum G, Malessa R. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multi-center randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care. 1999 22 : 1296 301.
49. Ames BN. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci USA. 2006 103 : 17589 94.
50. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy. 2007 3 : 614 15.
51. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol. 2007 66 : 525 32.
52. de la Torre JC, Aliev G. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. J Cereb Blood Flow Metab. 2005 25 : 663 72.
53. Blass JP, Gibson GE. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev Neurol. 1991 147 : 513 25.
54. Ando S, Tadenuma T, Tanaka Y, Fukui F, Kobayashi S, Ohashi Y, Kawabata T. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. J Neurosci Res. 2001 66 : 266 71.
55. Farr SA, Poon HF, Dogrukol-Ak D, Drake J, Banks WA, Eyerman E, Butterfield DA, Morley JE. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003 84 : 1173 83.
56. Ghirardi O, Giuliani A, Caprioli A, Ramacci MT, Angelucci L. Spatial memory in aged rats: population heterogeneity and effect of levocarnitine acetyl. J Neurosci Res. 1992 31 : 375 9.
57. Stoll S, Hartmann H, Cohen SA, Muller WE. The potent free radical scavenger alpha-lipoic acid improves memory in aged mice: putative relationship to NMDA receptor deficits. Pharmacol Biochem Behav. 1993 46 : 799 805.
58. Taglialatela G, Caprioli A, Giuliani A, Ghirardi O. Spatial memory and NGF levels in aged rats: natural variability and effects of acetyl-L-carnitine treatment. Exp Gerontol. 1996 31 : 577 87.